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END-STAGE RENAL DISEASE (ESRD) AND THE 
PROSPECTS FOR A MACHINE-FREE LIFE 
Robert W. Hanson 
Department of Chemistry 
University of North€rn Iowa 
Cedar Falls, Iowa 50614 
End-Stage Renal Disease (ESRD) is the term used by nephrologists 
describe cases of renal failure that have progressed to the point where continu 
viability depends on a substitution for kidney function. 
A generation ago ESRD was a terminal condition because there was no 
substitute for kidney function. Survival time depended on factors such as age 
-the presence of complicating diseases such as diabetes. Today, dialysis tech 
nologies are available that promise many additional years for ESRD patients. 
Kidney transplants have become fairly common but are preceded by some form 
of dialysis or followed by some form of dialysis in the event of transplant 
rejection. Except in unusual circumstances, the kidney transplant is not con-
sidered an option for persons past the age of fifty-seven. As a matter of fact, a 
form of treatment for ESRD is considered too expensive in some countries to be 
an acceptable part of nationally-financed health programs. In those countries, 
ESRD continues to be a terminal condition. 
Such is not the case in the United States. Congress made a decision in 1972 to 
pay 80 percent of the cost of kidney transplants and dialysis through the 
Medicare program for anyone whose kidneys failed. According to the Time article 
"One Miracle, Many Doubts" (Friedrich, 1984), the number of patients recei · 
such support reached 82,000 in the following decade, up from 10,300 the first 
year of the program. 
To the ESRD patient who normally would look forward to many more 
productive years, the generosity of American society is reason for a great 
sense of optimism as opposed to the resignation or despair that would otherwise 
prevail. It is one thing to be told that one's kidneys can no longer functio 
adequately. To be told that nothing can be done about it is quite another. 
The development of the "artificial kidney" - the hemodialysis machine - w 
a significant technological development in medicine. Such machines have no 
been engineered to smaller size and have monitoring systems that enable 
trained lay person such as a spouse to administer hemodialysis at home. 
However, most ESRD patients on hemodialysis go to a center three times 
week for 4 to 6-hour sessions, attached to the machine while the total volume 
the blood is circulated across a special semipermeable membrance in conta 
with a large volume of dialysate. Water and nitrogenous waste products diffu 
across the membrance from the blood to the dialysate, reducing the was 
products that build up between dialysis sessions. 
The intermittent nature of hemodialysis and the long sessions required ar 
obvious drawbacks. Surgery is required to create the proper vascular access t 
circulation of the blood into the machine and back. Connections to the machin 
are not unlike those required for blood transfusions. Between sessions on 
machine, the patient experiences the fatiguing and debilitating effects of the 
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increasing waste products in the blood. Post-session adjustment of the body's 
fluid balance often causes feelings of malaise. 
During the last four or five years, a machine-free form of self-administered 
dialysis has been made available to some ESRD patients. One form of this type of 
kidney-function substitute is called Continuous Ambulatory Peritoneal Dialysis 
or CAPD. 
The peritoneum is the membrance that lines the body cavity and holds the 
abdominal organs in place. The membrance is an effective dialyzer and contains a 
rich supply of capillaries. The CAPD patient carries dialysate solution in the 
abdominal cavity, introduced there through a surgically-installed catheter sys-
tem. In CAPD, as the name implies, dialysis is continuous; it is interrupted only 
to replace the dialysate three or four times a day. The replacement of spent 
dialysate with fresh dialysate is called an exchange and requires about 45 minutes. 
The patient is free to go about his usual activities between exchanges. 
The dialysate is a sterile solution of dextrose in water. Additional small 
amounts of solutes regulate the pH and provide the proper concentration of 
electrolytes. The only function of the dextrose is to act as an osmotic agent, and 
the osmotic pressure gradient between the dialysate and the blood is regulated 
by the percentage of dextrose in the solution. The choice of dextrose concentra-
tion depends on the patient's requirements for fluid removal. The usual volume of 
dialysate placed in the abdominal cavity during an exchange is 2000 mL. After a 
"dwell" of four to six hours, the volume may increase by as much as 800 mL, 
depending on the amount of water removed from the blood. This large volume of 
water removal is achieved by using the highest concentration of dextrose ( 4. 25 
percent); the lowest concentration of dextrose (1. 5 percent) removes up to 80 
rnL of water per exchange. An intermediate concentration (2. 5 percent) 
removes up to 500 mL of water per exchange. All three concentrations are 
equally effective in removing nitrogenous waste from the blood. 
Two waste products normally removed by the renal system are creatinine, a 
product of muscle metabolism, and urea, a waste product of protein digestion. 
Dialysis does not restore the blood levels of these products to normal, but the 
reduction is sufficient to reduce the fatiguing effects of uremia. 
It has been estimated that about 15 percent of the dialysis population is on 
CAPD. Ages of these CAPD patients range from newborns to 90 years, with a 
mean of about 50 years, according to the National Association of Patients on 
Hemodialysis and 11-ansplantation WAPHT News, 1982). 
Effective as CAPD is, it is not without side effects and risk of infection. The 
dialysate is an almost perfect medium for bacterial growth at body temperature, 
and the risk of peritonitis is ever present. Contamination of the catheter system 
that provides access to the peritoneal cavity can be avoided only by aseptic 
procedures during each exchange. The exchange involves removal of the plastic 
bag containing spent dialysate and replacing it with a fresh bag of dialysate. This 
requires the removal of the connecting device (the "spike") from the bag of spent 
dialysate and inserting it into the port on the fresh bag. The brief period during 
which the spike is exposed to air can result in contamination by air-borne 
bacteria. Inadvertently allowing it to contact any nonsterile surface may also 
result in bacterial contamination. 
Because peritonitis is almost inevitable, CAPD patients are given thorough 
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training on the addition of special antibiotics to the dialysate. This is done by 
injecting the medication into a special port on the bag of dialysate under sterile 
conditions. The protocol is specific for the treatment of peritonitis and lasts for 
ten days or more under the supervision of the nephrologist and close monitoring 
of CAPD clinic nurses. 
The osmotic agent used in CAPD is dextrose (glucose), and the body typically 
absorbs this sugar from the dialysate during CAPD. This can cause an increase in 
cholesterol and triglycerides in the blood; high levels may lead to diseases of the 
vascular system. For an ESRD patient with diabetes, the absorption of glucose 
from the dialysate can produce dangerous levels of blood sugar. For these and 
other reasons, CAPD patients use the lowest possible glucose concentration in 
the dialysate that will provide an adequate osmotic gradient for water removal 
ancf may add insulin directly to the bags of dialysate regularly. 
Another side effect of CAPD is the removal of water-soluble vitamins from the 
blood. Every CAPD patient must take daily oral doses of multiple vitamins and 
folic acid to replace those removed in the dialysate. 
A major effect of renal failure is the decreased production of the hormone 
erythropoeitin which stimulates the production of red blood cells. The resultant 
anemia is one of the first symptoms of renal failure. No way has been found, 
short of blood transfusions, to significantly raise the red blood cell count of ESRD 
patients. Because of the chronic problem of anemia, ESRD patients characteris-
tically find it difficult to perform physical activities that require a good supply of 
oxygen in the blood. However, mild exercise programs with appropriate 
demands are recommended and possible. Iron supplements are part of the oral 
medication regime for CAPD patients, but the limit to the effectiveness of such 
treatment is the volume of red blood cells. It is not unusual for a CAPD patient to 
have less than 60 percent of the normal red blood cell volume. 
Another function of the kidneys is to regulate fluid volume, which is a factor in 
determining blood pressure. Many ESRD patients suffer from hypertension, and 
it is not unusual for afflictions of the vascular system to plague those on dialysis. 
Fluid balance is another problem, and edema due to water retention in the tissues 
is common. Sodium and fluid intake have to be regulated in such cases. CAPD 
avoids the rapid fluctuations in blood pressure that characterize hemodialysis 
treatment and also affords more constant control of water retention. 
From the chemical viewpoint, one interesting complication of ESRD is the 
effect of inadequate removal of phosphate from the blood. Phosphate is a product 
of protein metabolism, and too high a level of phosphate in the blood can cause 
calcium release from the bones, with the possible result that the bones become 
weak and more subject to fracture. The excess calcium and phosphate ions 
combine to form insoluble calcium phosphate, and minute crystals of this material 
deposit in the soft tissues and the skin, where it causes itching. To avoid this, 
when blood studies show low calcium or high phosphate, phosphate binders such 
as aluminum hydroxide are prescribed to tie up the dietary phosphate in its 
passage through the body. Calcium supplements are sometimes prescribed 
because kidney failure usually results in a loss of the effectiveness of vitamin D, 
without which calcium cannot be absorbed normally from foods. 
Potassium can build up in the blood when the kidneys do not function, and 
dialysis does not fully correct this problem. A higher than normal level of 
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potassium in th~ blood has few obvious _symptoms and the effect cyi ~ insidious, 
ranging from high blood pressure and rrregular heart rhythm, to cardiac arrest. 
The best way to avoid this problem is to avoid foods that are high in potassium. 
Compared to hemodialysis patients, CAPD patients are less likely to have a 
problem with potassium level. 
In spite of its many advantages, CAPD is not for everyone on dialysis. For 
those who have the interest and the ability to care for themselves, it affords a 
degree of freedom that contributes much to the sense of well-being that is 
essential to a happy life. It can be a machine-free existence. On the other hand, 
recent technology provides for intermittent peritoneal dialysis through overnight 
automated cycling. Available only in some locations, these cyders afford freedom 
from the machine and from day-time exchanges during waking hours. Several 
exchanges occur while the patient is sleeping, and the removal of waste products 
from the blood is done effectively. Such machines take up about two square feet 
of floor space and stand about five feet high. Microprocessors regulate inflow, 
outflow, and dialysate temperature. Supply has not yet caught up with demand 
for these cyders, but in time they will offer a degree of freedom during the day 
not afforded by CAPD, though not providing for a truly machine-free life. 
A Personal Note 
When I was told in the fall of 1981 that I had lost two-thirds of my kidney 
function, my only symptoms were fatigue and shortness of breath on exertion. 
The clinical detection of anemia led to further tests, particularly the measure-
ment of creatinine and urea in my blood. These confirmed the diagnosis of 
chronic renal failure, and the prognosis was that my kidneys would eventually 
become inadequate, possibly failing altogether, necessitating some form of 
dialysis. That day didn't come until the fall of 1984 when the level of waste 
products in my blood and my increasing fatigue indicated that it was time to have 
the CAPD catheter surgically implanted. This decision was made jointly by me 
and my nephrologist, and was based on a long record of clinical measurements 
that showed gradual but unmistakable continued loss of kidney function. For 
three years, I had been gradually running down like a neglected spring-driven 
clock, and the gradual increase in my malaise had masked the way I really felt. 
After about five weeks on dialysis, I suddenly realized how much better I was 
feeling. I now feel that CAPD has given me a new lease on life, and even though 
the schedule of three or four exchanges a day is disruptive, I am thankful that I 
live in a country that has the resources to provide this kind of therapy. 
Aside from that, I have found CAPD to be a fascinating and very personal 
mode of treatment, full of interesting chemistry and biology. My students have 
found it to be an intriguing story that adds a human dimension to their studies. 
(Author's comments: Much of the content of this paper is drawn from the 
thorough training provided by the CAPD clinic personnel, particularly Carl J. 
Richards, M.D., Renal Dialysis Center, St. Francis Hospital, Waterloo, IA. Dr. 
Richards has reviewed the paper for its technical accuracy.) 
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